More recently, Dong et al. reported that MSCs with GOF mutations of SHP2 (PTPN11) regulated HSCs or myeloid progenitors malignant proliferation in bone marrow microenvironment and eventually promoted myeloproliferative neoplasm (MPN) [14]. The gene discussed is PTPN11; the disease is myeloproliferative neoplasm.